Not only pediatric hypopituitarism patients but also adult patients with hypopituitarism, GH deficiency, obesity, and MAFLD are reported to have positive effects from GH replacement therapy (21). The gene discussed is GH1; the disease is obesity due to melanocortin 4 receptor deficiency.